Search company, investor...

Predict your next investment

Corporation
HEALTHCARE | Pharmaceuticals / Drugs
ceres-pharma.com

About Ceres Pharma

Ceres Pharma is active in the development, production, and distribution of drugs, medical devices, biocides, cosmetics, food supplements, and pharmaceutical preparations in the Benelux and in Central and Eastern Europe. The company was founded in 2017 and is based in Ghent, Belgium.

Headquarters Location

Kortrijksesteenweg

Ghent, 1091,

Belgium

+32 9 296 47 70

Want to inform investors similar to Ceres Pharma about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Ceres Pharma News

Dacia Plant shareholders sold a majority stake to Ceres Pharma

Oct 22, 2022

acum 23 de secunde Călin Ioan Ianţa and Radu Ionescu-Heroiu, the shareholders of Dacia Plant, signed the agreement for the sale of the majority stake to Belgian-based Ceres Pharma. Dacia Plant is a wholly Romanian-owned company and one of the pioneers as well as a top three player in the development, production and distribution of qualitative and innovative natural food supplements in Romania. Ceres Pharma is a pharmaceutical company, founded in 2017 by CEO Mario Debel and Alychlo, which was recently acquired in 2021 by Naxicap Partners. The company is active in the development and distribution of drugs, medical devices, biocides, cosmetics, qualitative food supplements and pharmaceutical preparations in the Benelux and in Central and Eastern Europe.

Ceres Pharma Acquisitions

3 Acquisitions

Ceres Pharma acquired 3 companies. Their latest acquisition was Labophar on October 06, 2022.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

10/6/2022

$99M

Acquired

1

10/3/2022

Subscribe to see more

$99M

Subscribe to see more

10

5/17/2021

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/6/2022

10/3/2022

5/17/2021

Investment Stage

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Total Funding

Note

Acquired

Subscribe to see more

Subscribe to see more

Sources

1

10

10

Ceres Pharma Team

2 Team Members

Ceres Pharma has 2 team members, including current Founder, Chief Executive Officer, Mario Debel.

Name

Work History

Title

Status

Mario Debel

Founder, Chief Executive Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Mario Debel

Subscribe to see more

Work History

Title

Founder, Chief Executive Officer

Subscribe to see more

Status

Current

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.